PVd Regimen Highlighted as New Standard in Relapsed/Refractory Myeloma
Paul Richardson, MD, discusses the efficacy and tolerability of the combination of pomalidomide (Pomalyst), bortezomib (Velcade), and dexamethasone in patients with multiple myeloma.
Source: OncLive